APA (7th ed.) Citation

M, S., DR, R., KD, N., P, M., S, B., R, S., . . . DA, H. (2026). Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study. JMIR research protocols, 15, e88069. https://doi.org/10.2196/88069

Chicago Style (17th ed.) Citation

M, Shah, et al. "Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study." JMIR Research Protocols 15 (2026): e88069. https://doi.org/10.2196/88069.

MLA (9th ed.) Citation

M, Shah, et al. "Dovramilast for Erythema Nodosum Leprosum in Patients With Leprosy in Nepal: Protocol for a Phase 2 Open-Label Pilot Study." JMIR Research Protocols, vol. 15, 2026, p. e88069, https://doi.org/10.2196/88069.